Studies have found that DEPDC1 is associated with cell cycle progression, and abnormal expression of DEPDC1 can be observed in numerous malignant tumors including bladder cancer, breast cancer, and hepatocellular cancer (HCC).11, 12, 13, 14, 15, 16, 17, 18, 19. Here, DEPDC1 is linked to urinary bladder cancer.